Jul 5, 2026 Dopavision Presented Key Data from its MyopiaX-1 Clinical Trial at the 19th International Myopia Conference Dopavision
Jul 5, 2026 Dopavision Announces Topline Results in Clinical Trial of Targeted Photobiomodulation Approach for Progressive Myopia Dopavision
Jul 5, 2026 Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active Dopavision
Jul 5, 2026 Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials Dopavision
